The Athlete shall be granted a deadline of seven (7) days to indicate whether they intend to undertake a controlled pharmacokinetic s tudy, failing which the Results Management  Authority may proceed with the Results Management ; b) Urinary human chorionic gonadotrophin: follow the procedures  set out at Article 6 of the 2019 Technical Document for the Reporting & Management of Urinary Human Chorionic Gonadotrophin (hCG) and Luteinizing Hormone (LH) Findings in Male Athletes  (TD2019CG/LH) or any subsequent version of the Technical Document ;  c) Other Prohibited Substance  subject to specific Results Management  requirements in a Technical Document or other document issued by WADA : follow the procedures set out in the relevant Technical Document or other document issued by WADA .